Moolec Cash Conversion Cycle from 2010 to 2026

MLEC Stock   4.11  0.10  2.38%   
Moolec Science's Cash Conversion Cycle is increasing over the years with stable fluctuation. Cash Conversion Cycle is expected to dwindle to 16.09. During the period from 2010 to 2026 Moolec Science Cash Conversion Cycle annual values regression line had geometric mean of  31.44 and mean square error of  12,220. View All Fundamentals
 
Cash Conversion Cycle  
First Reported
2010-12-31
Previous Quarter
16.93
Current Value
16.09
Quarterly Volatility
109.73338646
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Moolec Science financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Moolec Science's main balance sheet or income statement drivers, such as Depreciation And Amortization of 26.9 M, Other Operating Expenses of 415.5 M or Total Operating Expenses of 150.3 M, as well as many indicators such as Price To Sales Ratio of 2.0, Dividend Yield of 0.0 or Days Sales Outstanding of 23.81. Moolec financial statements analysis is a perfect complement when working with Moolec Science Valuation or Volatility modules.
  
Build AI portfolio with Moolec Stock
Check out the analysis of Moolec Science Correlation against competitors.

Latest Moolec Science's Cash Conversion Cycle Growth Pattern

Below is the plot of the Cash Conversion Cycle of Moolec Science SA over the last few years. It is Moolec Science's Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Moolec Science's overall financial position and show how it may be relating to other accounts over time.
Cash Conversion Cycle10 Years Trend
Pretty Stable
   Cash Conversion Cycle   
       Timeline  

Moolec Cash Conversion Cycle Regression Statistics

Arithmetic Mean53.82
Geometric Mean31.44
Coefficient Of Variation203.90
Mean Deviation50.04
Median29.85
Standard Deviation109.73
Sample Variance12,041
Range464
R-Value0.22
Mean Square Error12,220
R-Squared0.05
Significance0.40
Slope4.79
Total Sum of Squares192,663

Moolec Cash Conversion Cycle History

2026 16.09
2025 16.93
2024 14.72
2023 479.12

About Moolec Science Financial Statements

Moolec Science stakeholders use historical fundamental indicators, such as Moolec Science's Cash Conversion Cycle, to determine how well the company is positioned to perform in the future. Although Moolec Science investors may analyze each financial statement separately, they are all interrelated. For example, changes in Moolec Science's assets and liabilities are reflected in the revenues and expenses on Moolec Science's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Moolec Science SA. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash Conversion Cycle 16.93  16.09 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Moolec Science SA is a strong investment it is important to analyze Moolec Science's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Moolec Science's future performance. For an informed investment choice regarding Moolec Stock, refer to the following important reports:
Check out the analysis of Moolec Science Correlation against competitors.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moolec Science. If investors know Moolec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moolec Science listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(258.69)
Revenue Per Share
2.041
Quarterly Revenue Growth
9.483
Return On Assets
(0.22)
Return On Equity
(1.75)
The market value of Moolec Science SA is measured differently than its book value, which is the value of Moolec that is recorded on the company's balance sheet. Investors also form their own opinion of Moolec Science's value that differs from its market value or its book value, called intrinsic value, which is Moolec Science's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moolec Science's market value can be influenced by many factors that don't directly affect Moolec Science's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moolec Science's value and its price as these two are different measures arrived at by different means. Investors typically determine if Moolec Science is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moolec Science's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.